Kemwell Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.90 Cr
as on 16-11-2024
- Company Age 52 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 278.72 Cr
as on 16-11-2024
- Revenue 92.51%
(FY 2023)
- Profit 346.84%
(FY 2023)
- Ebitda 174.30%
(FY 2023)
- Net Worth 6.56%
(FY 2023)
- Total Assets 6.56%
(FY 2023)
About Kemwell
The Corporate was formerly known as Indian Process Chemical Laboratory Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 2.90 Cr.
The company has closed loans amounting to ₹278.72 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Karan Bagaria and Shriram Chandak serve as directors at the Company.
- CIN/LLPIN
U70100KA1972PTC002151
- Company No.
002151
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 1972
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kemwell Private Limited offer?
Kemwell Private Limited offers a wide range of products and services, including Laboratory Autoclave & Sterilizers, Hospital Autoclave & Sterilizers, Pharmaceutical Services, Floor Cleaner, Liquid Cleaner, Laboratory Chamber, Stability Chamber, Business Consultant, Process Development Service, Oral Care Products.
Who are the key members and board of directors at Kemwell?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karan Bagaria  | Director | 30-Apr-2024 | Current |
| Shriram Chandak | Director | 01-Jun-1988 | Current |
Financial Performance and Corporate Structure Insights of Kemwell.
Kemwell Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 92.51% increase. The company also saw a substantial improvement in profitability, with a 346.84% increase in profit. The company's net worth moved up by a moderate rise of 6.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kemwell?
In 2022, Kemwell had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
North East Gases Pvt LtdActive 53 years 3 monthsKaran Bagaria and Shriram Chandak are mutual person
- Chemsworth Private LimitedActive 49 years 1 month
Karan Bagaria and Shriram Chandak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 06 Sep 2010 | ₹22.50 Cr | Satisfied |
Icici Bank Limited Creation Date: 11 Sep 2008 | ₹15.00 Cr | Satisfied |
Icici Bank Limited. Creation Date: 26 Jun 2006 | ₹17.00 Cr | Satisfied |
How Many Employees Work at Kemwell?
Unlock and access historical data on people associated with Kemwell, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kemwell, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kemwell's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
